4.4 Article

The potential of sec-butylpropylacetamide (SPD) and valnoctamide and their individual stereoisomers in status epilepticus

Journal

EPILEPSY & BEHAVIOR
Volume 49, Issue -, Pages 298-302

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yebeh.2015.04.012

Keywords

New antiepileptic drugs; Benzocliazepine-resistant status epilepticus; Stereoselective pharmacoldnetic and phannacodynamic analysis; Chiral switch

Funding

  1. BIAL
  2. BioAvenir
  3. Beohringer Ingelheim
  4. CTS Chemicals
  5. Desitin
  6. Janssen-Cilag
  7. Rekah
  8. Tombotech
  9. UCB Pharma
  10. Upsher-Smith

Ask authors/readers for more resources

sec-Butylpropylacetamide (SPD) is a one-carbon homologue of valnoctamide (VCD), a chiral constitutional isomer of valproic acid's (VPA) corresponding amide valpromide. Racemic-SPD and racemic-VCD possess a unique and broad-spectrum antiseizure profile superior to that of VPA. In addition, SPD blocks behavioral and electrographic status epilepticus (SE) induced by pilocarpine and the organophosphates soman and paraoxon. Valnoctamicle has similar activity as SPD in the soman-induced SE model. The activity of SPD and VCD against SE is superior to that of diazepam and midazolam in terms of rapid onset, potency, and ability to block SE when given 20 to 60 min after seizure onset sec-Butylpropylacetamicle and VCD possess two stereogenic carbons in their chemical structure and, thus, exist as a racemic mixture of four stereoisorners. The anticonvulsant activity of the individual stereoisomers of SPD and VCD was comparatively evaluated in several anticonvulsant rodent models including the benzodiazepine-resistant SE model sec-Butylpropylacetamide has stereoselective pharmacokinetics (PK) and pharmacodynamics (PD). The higher clearance of (2R,3S)-SPD and (25,3R)-SPD led to a 50% lower plasma exposure and, consequently, to a lower anticonvulsant activity compared to racemic-SPD and its two other stereoisomers. Racemic-SPD, (25,3S)-SPD, and (2R,3R)-SPD have similar anticonvulsant activities and PK profiles that are better than those of (2R,3S)-SPD and (25,3R)-SPD.Valnoctamide has a stereoselective PK with (25,3S)-VCD exhibiting the lowest clearance and, consequently, a twice higher plasma exposure than all other stereoisomers. Nevertheless, there was less stereoselectivity in VCD anticonvulsant activity, and each stereoisomer had similar ED50 values in most models. se c-Bulylpr up y la cc L a mide and VCD stereoisomers did not cause leratogenicily (i.e., neural rube defect) in mice al doses 3-12 times higher than their anticonvulsant-ED50 values. 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available